OpenAlex
PricingAboutJobs
Log inGet started
Work

Cardiovascular safety and benefits of GLP-1 receptor agonists

HTML

Year: 2017
Type: article
Source: Expert Opinion on Drug Safety
DOI: 10.1080/14740338.2017.1281246
Authors: Niels B. Dalsgaard, Andreas Brønden, Tina Vilsbøll, Filip K. Knop
Institutions: University of Copenhagen, Gentofte Hospital, Novo Nordisk Foundation Center for Basic Metabolic Research
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, cardiovascular safety, cardiovascular risk reduction, type 2 diabetes, liraglutide, semaglutide, lixisenatide, cardiovascular outcome trials, cardiovascular risk factors, weight loss, glycemic control
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk Fonden
Awards: G1551214306, G2790715585, G4899559972
OpenAlex ID: W2571824959
FWCI: 3.675
Cites: 86
Cited by: 38
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security